Keyphrases
Maximum Tolerated Dose
100%
Azidothymidine
100%
Phase I Study
100%
CDDP
100%
Advanced Malignancies
100%
Dose Level
75%
Steady State
50%
Dose-limiting Toxicity
50%
Myelosuppression
50%
Cell Culture
25%
Malignancy
25%
Pharmacokinetics
25%
Cisplatin
25%
Drug Combination
25%
Combination Therapy
25%
Steady-state Concentration
25%
Plasma Parameters
25%
Cisplatin Resistance
25%
Continuous Intravenous Infusion
25%
Zidovudine
25%
Stable Disease
25%
Plasma Pharmacokinetics
25%
Chemotherapy Efficacy
25%
Drug Resistance Reversal
25%
Chemotherapeutic Regimens
25%
4-cycle
25%
Additive Toxicity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Zidovudine
100%
Maximum Tolerated Dose
28%
Cisplatin
14%
Bone Marrow Suppression
14%
Pharmacokinetics
14%
Chemotherapy
7%
Cell Culture
7%
Combination Therapy
7%
Drug Resistance
7%
Combination Drug
7%
Diseases
7%